Insight
Estela Rodriguez
Estela Rodriguez/doctors.umiamihealth.org

Estela Rodriguez: AI to Predict Immunotherapy Response in Advanced NSCLC

Estela Rodriguez, Associate Director of Community Outreach-Thoracic Oncology and Co-Lead Thoracic Site Disease Group, Associate Director of Community Outreach at Sylvester Comprehensive Cancer Center, shared a post on X:

“Looking forward to seeing more of this work: Deep Learning AI Model for Predicting Immunotherapy Response in Advanced NSCLC using available pathology histology slides (in addition to PDL1 expression).”

Title: Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer

Authors: Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, Joao Alessi, Alessio Cortellini, Fabrizio Citarella, Lorenzo Nibid, Giuseppe Perrone, Elio Adib, Claudia Fulgenzi, Cassio Hidalgo Filho, Alessandro Di Federico, Falah Jabar, Sayed Hashemi, Ilias Houda, Elin Richardsen, Lill-Tove Rasmussen Busund, Tom Donnem, Idris Bahce, David Pinato, Åslaug Helland, Lynette Sholl, Mark Awad, David Kwiatkowski

Read the Full Article on JAMA Network.

Estela Rodriguez: AI to Predict Immunotherapy Response in Advanced NSCLC

More posts featuring Estela Rodriguez on OncoDaily.

AI model Alessandro Di Federico Alessio Cortellini Åslaug Helland Biagio Ricciuti cancer Cassio Hidalgo Filho Claudia Fulgenzi David Kwiatkowski David Pinato Elin Richardsen Elio Adib Estela Rodriguez Fabrizio Citarella Falah Jabar Giuseppe Perrone Idris Bahce Ilias Houda immunotherapy immunotherapy response João Alessi Lill-Tove Rasmussen Busund Lorenzo Nibid Lung cancer Lynette Sholl Mark Awad Masoud Tafavvoghi Mehrdad Rakaee NSCLC OncoDaily Oncology Sayed Hashemi Tom Donnem